Rocco Rotello currently serves as the Director of Laboratory Operations at STAQ Pharma, a prominent 503b sterile drug compounding company based in Columbus, Ohio. In this pivotal role, Rocco is dedicated to ensuring the delivery of safe and effective sterile injectable drug products to patients...
Rocco Rotello currently serves as the Director of Laboratory Operations at STAQ Pharma, a prominent 503b sterile drug compounding company based in Columbus, Ohio. In this pivotal role, Rocco is dedicated to ensuring the delivery of safe and effective sterile injectable drug products to patients requiring critical therapies. His leadership is instrumental in supplying essential medications to hospital networks across the United States, addressing urgent healthcare needs with precision and reliability.
At STAQ Pharma, Rocco spearheads the development of Analytical Chemistry and Microbiology Lab functions, which are vital for supporting product development and commercial release operations in both Columbus and Denver facilities. His expertise in pharmaceutical microbiology and chemistry allows him to navigate the complexities of cGMP (current Good Manufacturing Practices) compliance, ensuring that all laboratory functions meet stringent regulatory standards. Rocco's commitment to achieving certification for the lab operations not only enhances the quality of STAQ Pharma's offerings but also reinforces the company's reputation as a trusted provider in the pharmaceutical industry.
With a robust background in immunology, biotechnology, and R&D, Rocco brings a wealth of knowledge to his role. His management skills are complemented by a passion for teaching, enabling him to mentor and develop the next generation of scientists within the organization. By fostering a culture of innovation and excellence, Rocco is poised to drive STAQ Pharma's mission forward, ultimately improving patient outcomes through the delivery of high-quality sterile injectable products.
